135 related articles for article (PubMed ID: 11734136)
1. [Non-small cell bronchogenic carcinoma in advanced stages: prognostic value of weight loss and clinical implications].
Gullón J; Fernández R; Rubinos G; Medina A; Suárez I; González I
Arch Bronconeumol; 2001 Dec; 37(11):477-81. PubMed ID: 11734136
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy and survival in advanced non-small cell lung carcinoma: is pneumologists' skepticism justified?].
Gullón Blanco JA; Suárez Toste I; Fernández Alvarez R; Rubinos Cuadrado G; Medina Gonzálvez A; Galindo Morales R; González Martín IJ
Arch Bronconeumol; 2006 Jun; 42(6):273-7. PubMed ID: 16827975
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
4. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
[TBL] [Abstract][Full Text] [Related]
5. [Small-cell nonanaplastic bronchogenic carcinoma. The new stage I].
Padilla J; Peñalver JC; Calvo V; García Zarza A; Pastor J; Blasco E; París F
Arch Bronconeumol; 2000 Feb; 36(2):68-72. PubMed ID: 10726193
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
7. [Model of mortality risk in stage I non-small cell bronchogenic carcinoma].
Padilla J; Peñalver J; Calvo V; García Zarza A; Pastor J; Blasco E; París F
Arch Bronconeumol; 2001 Jun; 37(6):287-91. PubMed ID: 11412527
[TBL] [Abstract][Full Text] [Related]
8. [Non-small cell bronchogenic cancer in stage IA: mortality patterns after surgery].
Padilla J; Peñalver JC; Jordá C; Calvo V; Escrivá J; Cerón J; García Zarza A; Pastor J; Blasco E
Arch Bronconeumol; 2005 Apr; 41(4):180-4. PubMed ID: 15826526
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department].
Moro D; Nagy-Mignotte H; Bolla M; Colonna M; Brichon PY; Brambilla C; Schaerer R; Vrousos C
Bull Cancer; 1997 Feb; 84(2):155-61. PubMed ID: 9180838
[TBL] [Abstract][Full Text] [Related]
10. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
11. [Postoperative survival in stage II non-small-cell bronchogenic carcinoma].
Calvo Medina V; Padilla Alarcón J; París Romeu F; Blasco Armengod E; Pastor Guillem J; García Zarza A
Arch Bronconeumol; 2001 Jan; 37(1):19-26. PubMed ID: 11181226
[TBL] [Abstract][Full Text] [Related]
12. [Tumor markers as prognostic factors in non-small-cell bronchial carcinoma].
Nieder C; Nestle U; Ukena D; Niewald M; Sybrecht GW; Schnabel K
Strahlenther Onkol; 1995 Oct; 171(10):587-93. PubMed ID: 8571178
[TBL] [Abstract][Full Text] [Related]
13. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
14. [Results of surgery of non-small cell primary bronchial cancers. Retrospective analysis of 452 resections].
Thomas P; Massard G; Sielezneff I; Morati N; Giudicelli R; Garbe L; Reboud E; Fuentes P
Rev Mal Respir; 1992; 9(5):531-7. PubMed ID: 1332149
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
16. [The prognosis following surgical resection of small-cell nonanaplastic bronchogenic carcinoma according to the new staging guideline: an analysis of 1433 patients].
Padilla J; Calvo V; García Zarza A; Pastor J; Blasco E; París F
Arch Bronconeumol; 1999 Nov; 35(10):483-7. PubMed ID: 10618748
[TBL] [Abstract][Full Text] [Related]
17. [Resected non-small cell bronchogenic carcinoma stage pIIIA-N2. Which patients will benefit most from adjuvant therapy?].
Gómez AM; Jarabo JR; Fernandez C; Calatayud J; Fernández E; Torres AJ; Balibrea JL; Hernando F;
Cir Esp; 2014 Apr; 92(4):277-82. PubMed ID: 23453425
[TBL] [Abstract][Full Text] [Related]
18. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.
Naruke T; Tsuchiya R; Kondo H; Asamura H
Ann Thorac Surg; 2001 Jun; 71(6):1759-64. PubMed ID: 11426744
[TBL] [Abstract][Full Text] [Related]
20. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
